Acquisition Primes Airborne For Claims Overhaul
This article was originally published in The Tan Sheet
GF Capital Private Equity Fund is overhauling Airborne Inc. to steer the firm clear of the regulatory issues that have plagued it
You may also be interested in...
Under a settlement with the Federal Trade Commission announced Aug. 14, the maker of Airborne dietary supplement products must cease unsubstantiated health-related claims and contribute up to $6.5 million to an existing consumer redress fund
CNS sees its proposed acquisition by Glaxo as an opportunity to protect the intellectual property rights and market share of its Breathe Right brand with the additional resources available to a larger company
The recent success of Tylenol Extra Strength Rapid Release Gels has caught the attention of private labelers